(Q40139417)

English

Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine

scientific article published on 11 April 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

vector-borne disease

0 references

0 references

1 reference

based on heuristic

inferred from title

Western equine encephalitis

1 reference

based on heuristic

inferred from title

equine encephalitis

1 reference

based on heuristic

inferred from title

Western equine encephalitis virus

object named as

western equine encephalitis virus

1 reference

based on heuristic

inferred from title

author name string

Josh Q H Wu

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Nicole D Barabé

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Damon Chau

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Christina Wong

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

George R Rayner

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Wei-Gang Hu

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Les P Nagata

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

0 references

publication date

11 April 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

4368-4375

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Medically important arboviruses of the United States and Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Infectivity variation and genetic diversity among strains of Western equine encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Arbovirus infections of laboratory workers. Extent of problem emphasizes the need for more effective measures to reduce hazards

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Recombinant chimeric western and eastern equine encephalitis viruses as potential vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Efficacy of DNA vaccination against western equine encephalitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Complete genomic RNA sequence of western equine encephalitis virus and expression of the structural genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Construction and characterization of monoclonal antibodies against western equine encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Inactivated western equine encephalomyelitis vaccine propagated in chick embryo cell culture. Clinical and serological evaluation in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Adenoviruses as vaccine vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Adenoviral vectors for mucosal vaccination against infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Adenovirus-based genetic vaccines for biodefense

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

Cross-Protection in Hamsters Immunized with Group A Arbovirus Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.042

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.03.042

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40139417&oldid=1886720789"